Free Equity Delivery
Flat ₹10 per Trade in Intraday & F&O
Dr.Agarwal's Health Care IPO is a book build issue of ₹3,027.26 crores. The issue is a combination of fresh issue of 0.75 crore shares aggregating to ₹300.00 crores and offer for sale of 6.78 crore shares aggregating to ₹2,727.26 crores.
Dr.Agarwal's Health Care IPO bidding started from Jan 29, 2025 and ended on Jan 31, 2025. The allotment for Dr.Agarwal's Health Care IPO was finalized on Feb 3, 2025. The shares got listed on BSE, NSE on Feb 4, 2025.
Dr.Agarwal's Health Care IPO price band is set at ₹402.00 per share . The lot size for an application is 35. The minimum amount of investment required by an retail is ₹14,070 (35 shares) (based on upper price). The lot size investment for sNII is 15 lots (525 shares), amounting to ₹2,11,050, and for bNII, it is 72 lots (2,520 shares), amounting to ₹10,13,040.
The issue includes a reservation of up to 15,79,399 shares for employees offered at a discount of ₹0.00 to the issue price.
Kotak Mahindra Capital Co.Ltd. is the book running lead manager and Kfin Technologies Ltd. is the registrar of the issue.
Refer to Dr.Agarwal's Health Care IPO RHP for detailed Information.
| IPO Date | January 29, 2025 to January 31, 2025 |
| Listing Date | February 4, 2025 |
| Face Value | ₹1 per share |
| Issue Price Band | ₹382 to ₹402 per share |
| Issue Price Final | ₹402 per share |
| Lot Size | 35 Shares |
| Sale Type | Fresh Capital-cum-Offer for Sale |
| Total Issue Size | 7,53,04,970 shares (aggregating up to ₹3,027.26 Cr) |
| Fresh Issue | 74,62,686 shares (aggregating up to ₹300.00 Cr) |
| Offer for Sale | 6,78,42,284 shares of ₹1 (aggregating up to ₹2,727.26 Cr) |
| Issue Type | Bookbuilding IPO |
| Listing At | BSE, NSE |
| Share Holding Pre Issue | 30,84,17,160 shares |
| Share Holding Post Issue | 31,58,79,846 shares |
Dr.Agarwal's Health Care IPO offers total 7,53,04,970 shares. Out of which 3,62,97,998 (48.20%) allocated to QIB, 1,45,19,200 (19.28%) allocated to QIB (Ex- Anchor), 1,08,89,400 (14.46%) allocated to NII, 2,54,08,599 (33.74%) allocated to RII and 2,17,78,798 (28.92%) allocated to Anchor investors.
| Investor Category | Shares Offered | Maximum Allottees |
|---|---|---|
| QIB Shares Offered | 3,62,97,998 (48.20%) | NA |
| − Anchor Investor Shares Offered | 2,17,78,798 (28.92%) | NA |
| − QIB (Ex. Anchor) Shares Offered | 1,45,19,200 (19.28%) | NA |
| NII (HNI) Shares Offered | 1,08,89,400 (14.46%) | NA |
| − bNII > ₹10L | 72,59,600 (9.64%) | 13,827 |
| − sNII < ₹10L | 36,29,800 (4.82%) | 6,913 |
| Retail Shares Offered | 2,54,08,599 (33.74%) | 7,25,959 |
| Employee Shares Offered | 15,79,399 (2.10%) | NA |
| Shareholders Shares Offered | 11,29,574 (1.50%) | NA |
| Total Shares Offered | 7,53,04,970 (100.00%) |
| Application Category | Maximum Bidding Limits | Bidding at Cut-off Price Allowed |
|---|---|---|
| Only RII | Up to Rs 2 Lakhs | Yes |
| Only sNII | Rs 2 Lakhs to Rs 10 Lakhs | No |
| Only bNII | Rs 10 Lakhs to NII Reservation Portion | No |
| Only shareholder | Up to Rs 2 Lakhs | Allowed only if bidding amount is upto Rs 2 lakhs |
| Only employee | Up to Up to Rs 5 Lakhs | Yes |
| Employee + Shareholder |
|
Yes |
| Employee + Shareholder + RII/NII |
|
Yes for shareholder/employee/RII |
| Shareholder + RII/NII |
|
Yes for shareholder/RII |
| Employee + RII/NII |
|
Yes for shareholder/RII |
Note: To be eligible for the Shareholder Quota, you must hold shares in one of the following companies:
Dr.Agarwal's Health Care IPO raises ₹875.51 crore from anchor investors. Dr.Agarwal's Health Care IPO Anchor bid date is January 28, 2025. Dr.Agarwal's Health Care IPO Anchor Investors list
| Bid Date | January 28, 2025 |
| Shares Offered | 2,17,78,798 |
| Anchor Portion Size (In Cr.) | 875.51 |
| Anchor lock-in period end date for 50% shares (30 Days) | March 2, 2025 |
| Anchor lock-in period end date for remaining shares (90 Days) | May 1, 2025 |
Dr.Agarwal's Health Care IPO opens on January 29, 2025, and closes on January 31, 2025.
| IPO Open Date | Wed, Jan 29, 2025 |
| IPO Close Date | Fri, Jan 31, 2025 |
| Tentative Allotment | Mon, Feb 3, 2025 |
| Initiation of Refunds | Tue, Feb 4, 2025 |
| Credit of Shares to Demat | Tue, Feb 4, 2025 |
| Tentative Listing Date | Tue, Feb 4, 2025 |
| Cut-off time for UPI mandate confirmation | 5 PM on Fri, Jan 31, 2025 |
Investors can bid for a minimum of 35 shares and in multiples thereof. The following table depicts the minimum and maximum investment by Individual Investors (Retail) and HNI in terms of shares and amount.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 35 | ₹14,070 |
| Retail (Max) | 14 | 490 | ₹1,96,980 |
| S-HNI (Min) | 15 | 525 | ₹2,11,050 |
| S-HNI (Max) | 71 | 2,485 | ₹9,98,970 |
| B-HNI (Min) | 72 | 2,520 | ₹10,13,040 |
Note : The value will be calculated using Equity Dilution = Share Holding Pre Issue - Share Holding Post Issue
Incorporated in 2010, Dr. Agarwal's Health Care Limited offers a comprehensive range of eye care services, including cataract and refractive surgeries, consultations, diagnoses, non-surgical treatments, and the sale of optical products, contact lenses, accessories, and eye care-related pharmaceutical items.
As of September 30, 2024, there were 737 doctors providing care to patients across the company's facilities. During this period, the company served 2.13 million patients and performed 220,523 surgeries. In the six months leading up to September 30, 2024, they served 1.15 million patients and conducted 140,787 surgeries.
The Services provided by the company are:-
Cataract surgeries Offer cataract surgical treatments at its Facilities, such as small incision cataract surgery, phacoemulsification, robotic cataract surgery and glued intraocular lens treatments;
Refractive surgeries: Refractive surgeries are procedures that correct eye refractive errors, helping individuals reduce or eliminate their need for glasses and contact lenses. The main types include LASIK, SMILE, implantable collamer lenses, and photorefractive keratectomy (PRK).
Other surgeries: Offer a range of other surgical treatments for eye ailments, such as surgical retinal treatments, corneal transplantation and pinhole pupilloplasty, oculoplasty and surgeries for the treatment of glaucoma and pterygium.
As of September 30, 2024, the company's Indian network has 28 hubs (Tertiary Facilities, including three COEs) and 165 spokes (53 Primary and 112 Secondary Facilities).
As of September 30, 2024, the company has a presence in India across 117 metro and non-metro cities spanning 14 states and four union territories through 193 Facilities.
Competitive Strength
| Period Ended | 30 Sep 2024 | 31 Mar 2024 | 31 Mar 2023 | 31 Mar 2022 |
| Assets | 3,393.41 | 2,752.82 | 1,825.17 | 1,026.13 |
| Total Income | 837.94 | 1,376.45 | 1,031.49 | 713.78 |
| Profit After Tax | 39.56 | 95.05 | 103.23 | 43.16 |
| Net Worth | 1,502.67 | 1,337.68 | 627.83 | 212.34 |
| Reserves and Surplus | 1,509.11 | 1,365.86 | 652.63 | 236.27 |
| Total Borrowing | 373.68 | 387.79 | 356.18 | 290.18 |
| Amount in ₹ Crore | ||||
The market capitalization of Dr.Agarwal's Health Care IPO is ₹12698.37 Cr.
KPI as of Sun, Mar 31, 2024.
| KPI | Values |
|---|---|
| ROE | 9.33% |
| ROCE | 14.61% |
| RoNW | 6.21 |
| PAT Margin | 6.90% |
| Price to Book Value | 7.96 |
| Pre IPO | Post IPO | |
|---|---|---|
| EPS Rs | 3.08 | 2.51 |
| P/E (x) | 130.44 | 160.48 |
The Company proposes to utilise the Net Proceeds from the Fresh Issue towards funding of the following objects:
[Dilip Davda] The company is engaged in eye care business providing all eye health related treatments. While its top line marked steady growth for the reported periods, it posted pressure on margins for FY23. It has nearly 25% market share in its business of eye-care related services. Based on recent financial performance, the issue appears exorbitantly priced. Only well-informed/cash surplus/risk seekers may park moderate funds for long term considering future prospects. Read detail review...
| Listing Date | February 4, 2025 |
| BSE Script Code | 544350 |
| NSE Symbol | AGARWALEYE |
| ISIN | INE943P01029 |
| Final Issue Price | ₹402 per share |
| NSE Listing Group | BE (Trade to Trade) |
| BSE Listing Group | B |
Dr.Agarwal's Health Care Ltd.
1 st Floor, Buhari Towers
No.4, Moores Road, Off Greams Road,
Near Asan Memorial School, Chennai 600 006
Chennai, Tamil Nadu
Phone: +91 44 4378 7777
Email: secretarial@dragarwal.com
Website: https://dragarwals.co.in/
Kfin Technologies Ltd.
Phone: 04067162222, 04079611000
Email: ahcl.ipo@kfintech.com
Website: https://ipostatus.kfintech.com/
Dr.Agarwal's Health Care IPO is a main-board IPO of 7,53,04,970 equity shares of the face value of ₹1 aggregating up to ₹3,027.26 Crores. The issue is priced at ₹402 per share. The minimum order quantity is 35.
The IPO opens on January 29, 2025, and closes on January 31, 2025.
Kfin Technologies Ltd. is the registrar for the IPO. The shares are proposed to be listed on BSE, NSE.
Zerodha customers can apply online in Dr.Agarwal's Health Care IPO using UPI as a payment gateway. Zerodha customers can apply in Dr.Agarwal's Health Care IPO by login into Zerodha Console (back office) and submitting an IPO application form.
Steps to apply in Dr.Agarwal's Health Care IPO through Zerodha
Visit Zerodha IPO Application Process Review for more detail.
The Dr.Agarwal's Health Care IPO opens on January 29, 2025 and closes on January 31, 2025.
Dr.Agarwal's Health Care IPO lot size is 35, and the minimum amount required for application is ₹14,070.
You can apply in Dr.Agarwal's Health Care IPO online using either UPI or ASBA as a payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO Application is offered by brokers who don't offer banking services. Read more detail about applying IPO online through Zerodha, Upstox, 5Paisa, Nuvama, HDFC Bank, and SBI Bank.
The finalization of Basis of Allotment for Dr.Agarwal's Health Care IPO will be done on Monday, February 3, 2025, and the allotted shares will be credited to your demat account by Tuesday, February 4, 2025. Check the Dr.Agarwal's Health Care IPO allotment status.
The Dr.Agarwal's Health Care IPO listing date is on Tuesday, February 4, 2025.
Useful Articles
RHP